"Danco stated that the circuit court's ruling injects immediate confusion and upheaval into highly time-sensitive medical decisions, forcing all parties to guess what is allowed."
"Louisiana argues that allowing the drug to be dispensed through the mail ignores the threat of complications from mifepristone, such as sepsis and hemorrhaging."
"The three-judge circuit court agreed with Louisiana that the looser rule facilitates nearly 1,000 illegal abortions in Louisiana per month."
"Danco warned that the ruling would cause chaos, impacting providers, patients, and pharmacies involved in the prescription process."
Danco Laboratories filed an emergency appeal to the US Supreme Court to pause a ruling requiring in-person exams for mifepristone prescriptions. The Fifth Circuit Court reinstated this requirement, blocking telemedicine prescriptions. Danco argued that the ruling creates confusion and chaos in medical decisions. Louisiana contends that mail delivery of the drug circumvents abortion bans and poses health risks. The FDA is reviewing mifepristone's safety following requests from Republican attorneys general. The appeals court ruled that the in-person requirement should be reinstated during Louisiana's appeal process.
Read at www.theguardian.com
Unable to calculate read time
Collection
[
|
...
]